(Q45061892)

English

Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia

scientific article published on 15 September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 December 2017

Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia (English)

1 reference

Europe PubMed Central

9 December 2017

author name string

Frédérique Gatelais

1

1 reference

Europe PubMed Central

9 December 2017

Jacques Berthelot

2

1 reference

Europe PubMed Central

9 December 2017

Frédérique Beringue

3

1 reference

Europe PubMed Central

9 December 2017

Philippe Descamps

4

1 reference

Europe PubMed Central

9 December 2017

Dominique Bonneau

5

1 reference

Europe PubMed Central

9 December 2017

Jean-Marie Limal

6

1 reference

Europe PubMed Central

9 December 2017

Régis Coutant

7

1 reference

Europe PubMed Central

9 December 2017

language of work or name

0 references

publication date

15 September 2004

1 reference

Europe PubMed Central

9 December 2017

Pediatric Research

1 reference

Europe PubMed Central

9 December 2017

56

1 reference

Europe PubMed Central

9 December 2017

5

1 reference

Europe PubMed Central

9 December 2017

701-705

1 reference

Europe PubMed Central

9 December 2017

https://scigraph.springernature.com/pub.10.1203/01.pdr.0000142733.50918.6e

0 references

Congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Longitudinal measurements of 17alpha-hydroxyprogesterone in premature infants during the first three months of life

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN).

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Multiple courses of antenatal steroids: risks and benefits

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Comparison of single and repeated antenatal corticosteroid therapy to prevent neonatal death and morbidity in the preterm infant.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Plasma 17-hydroxyprogesterone concentrations in ill newborn infants

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Fetal growth and the function of the adrenal cortex in preterm infants

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

EXTENSIVE PERSONAL EXPERIENCE: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 532 Pregnancies

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000142733.50918.6E

21 January 2018

Identifiers

10.1203/01.PDR.0000142733.50918.6E

1 reference

Europe PubMed Central

9 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45061892&oldid=2064363214"